PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Huth, C. ; Illig, T. ; Herder, C.* ; Gieger, C. ; Grallert, H. ; Vollmert, C. ; Rathmann, W.* ; Hamid, Y.H.* ; Pedersen, O.* ; Hansen, T.* ; Thorand, B. ; Meisinger, C. ; Döring, A. ; Klopp, N. ; Gohlke, H. ; Lieb, W.* ; Hengstenberg, C.* ; Lyssenko, V.* ; Groop, L.* ; Ireland, H.* ; Stephens, J.W.* ; Wernstedt Asterholm, I.* ; Jansson, J.-O.* ; Boeing, H.* ; Möhlig, M.* ; Stringham, H.M.* ; Boehnke, M.* ; Tuomilehto, J.* ; Fernandez-Real, J.-M.* ; Lopez-Bermejo, A.* ; Gallart, L.* ; Vendrell, J.* ; Humphries, S.E.* ; Kronenberg, F.* ; Wichmann, H.-E. ; Heid, I.M.

Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G>C with circulating glucose levels, interleukin-6 levels, and body mass index.

Ann. Med. 41, 128-138 (2009)
DOI PMC
Open Access Gold as soon as Publ. Version/Full Text is submitted to ZB.
Background. Several studies have investigated associations between the -174GC single nucleotide polymorphism (rs1800795) of the IL6 gene and phenotypes related to type 2 diabetes mellitus (T2DM) but presented inconsistent results. Aims. This joint analysis aimed to clarify whether IL6 -174GC was associated with glucose and circulating interleukin-6 concentrations as well as body mass index (BMI). Methods. Individual-level data from all studies of the IL6-T2DM consortium on Caucasian subjects with available BMI were collected. As study-specific estimates did not show heterogeneity (P0.1), they were combined by using the inverse-variance fixed-effect model. Results. The main analysis included 9440, 7398, 24,117, or 5659 non-diabetic and manifest T2DM subjects for fasting glucose, 2-hour glucose, BMI, or circulating interleukin-6 levels, respectively. IL6 -174 C-allele carriers had significantly lower fasting glucose (-0.091 mmol/L, P=0.014). There was no evidence for association between IL6 -174GC and BMI or interleukin-6 levels, except in some subgroups. Conclusions. Our data suggest that C-allele carriers of the IL6 -174GC polymorphism have lower fasting glucose levels on average, which substantiates previous findings of decreased T2DM risk of these subjects.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
5.435
1.580
32
49
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Blood glucose; body mass index; diabetes mellitus type 2; genes; inflammation mediators; interleukin-6; intermediate phenotype; meta-analysis; molecular epidemiology; single nucleotide polymorphism; g/c promoter polymorphism; type-2 diabetes-mellitus; myocardial-infarction; gene promoter; risk-factors; plasma interleukin-6; metabolic syndrome; metaanalysis; obesity; cohort
Language english
Publication Year 2009
HGF-reported in Year 0
ISSN (print) / ISBN 0785-3890
e-ISSN 1365-2060
Journal Annals of Medicine
Quellenangaben Volume: 41, Issue: 2, Pages: 128-138 Article Number: , Supplement: ,
Publisher Informa Healthcare
Reviewing status Peer reviewed
Institute(s) Institute of Epidemiology (EPI)
POF-Topic(s) 30503 - Chronic Diseases of the Lung and Allergies
Research field(s) Genetics and Epidemiology
PSP Element(s) G-503900-001
G-503900-003
PubMed ID 18752089
DOI 10.1080/07853890802337037
Scopus ID 61349133510
Erfassungsdatum 2009-07-09
[➜Report correction]